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Abstract 
 
Background: Caffeine-related health incidents in New Zealand have escalated over the 
last two decades. Research suggests that in order to reduce the risk of substance-related 
harm, it is important to understand the consumers’ motivations for its use, especially in 
tertiary students who are presumed to be at a higher risk due to seeking out caffeine’s 
well-known cognitive benefits. The public health consequences of caffeine consumption 
can only be determined once data is available on the amount of caffeine currently being 
consumed by New Zealanders, and New Zealand-based studies that have examined 
caffeine consumption are limited. 
Aim:  The aim of this study was to examine the caffeine consumption habits of tertiary 
students in New Zealand; their motivations for use, and experiences across a broad 
range of caffeine products. 
Method: A previously designed caffeine consumption habits questionnaire (CaffCo) 
was administered to 317 tertiary students via the online survey software, Qualtrics.  
Results: Of the total dataset, 99.1% (n= 314), consumed at least one source of caffeine 
in their diet. The caffeine sources with the highest prevalence of use were chocolate 
(81.7% of participants), coffee (76.3%) and tea (71.6%). Motivations for consumption 
appear to differ between various caffeine sources. In caffeine consumers, the median 
estimated daily caffeine consumption was 146.73 mg·day-1 (n= 314), or 2.25  
mg? kgbw-1? day-1 (n= 281), with coffee contributing 61.4% to the total daily caffeine 
consumption. An estimated 14.3% (n= 45) of caffeine consumers exceeded a suggested 
‘safe limit’ of 400 mg? day-1, where cigarette smoking was the only participant 
demographic/characteristic which increased the likelihood of exceeding this level. 
Caffeine was co-ingested with alcohol by 38.5% (n= 122) of the participants, and those 
with paid employment or those who smoked cigarettes were more likely to do so. The 
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majority of caffeine consumers (84.7%, n= 265) reported experiencing at least one 
adverse symptom post caffeine consumption, 64.2% reported being dependent on at 
least one caffeine source, and 47.3% (n= 152) of total participants reported experiencing 
at least one withdrawal symptom in the past.  
Conclusions: These findings provide critical information for implementing caffeine-
related risk-reduction strategies for New Zealand tertiary students. 
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